ENDOCRINOLOGIC AND METABOLIC DRUGS ADVISORY COMMITTEE
July 27, 2001
Forteo (teriparatid injection, rDNA origin) NDA 21-318
Eli Lilly and Company pdf
The statements contained in this document are those of the product's sponsor, not FDA, and FDA does not necessarily agree with the sponsor's statements. FDA has not made a final determination about the safety or effectiveness of the product described in this document.
FDA Backgrounder htm